Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
The Biden administration's eleventh hour move to expand Medicare coverage for anti-obesity drugs is likely to be popular ...
The Biden administration is proposing to cover drugs like Ozempic, which is used to treat heart disease, diabetes and obesity ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.
A new rule proposed by CMS presents alterations to the Medicare program, including expanded coverage for anti-obesity ...
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.
A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be ...
The Biden administration is proposing a new rule to significantly expand the coverage of weight-loss drugs for Americans on ...
Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...
The Biden-Harris administration wants to expand coverage of anti-obesity medications in the Medicare and Medicaid programs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback